Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Feng ^a   Ren, Xingsheng ^a   Zhao, Mingxia ^a   Zhou, Bing ^a   Han, Ying ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989950315     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34621     Document Type: Article

References (56)

1. Chiong, M. et al. Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation. Front Cell Dev Biol 2, 72 (2014).
2. Ho-Tin-Noe, B. et al. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-gamma trigger intramedial angiogenesis in a smooth muscle cell-dependent manner. Circ Res 109, 1003-1014 (2011).
3. Ragolia, L., Palaia, T., Paric, E. & Maesaka, J. K. Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem 278, 22175-22181 (2003).
4. Rudijanto, A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 39, 86-93 (2007).
5. ROSS, R. Atherosclerosis-an inflammatory disease. N Engl J Med. 340, 115-126 (1999).
6. Pacurari, M., Kafoury, R., Tchounwou, P. B. & Ndebele, K. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014, 689360 (2014).
7. Lusis, A. J. Atherosclerosis. Nature 407, 233-241(2000).
8. Xiao, X. et al. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ ROS and PI3K/NO pathways. Exp Cell Res 336, 58-65 (2015).
9. Hope, D. I. et al. Vascular Remodeling in Hypertension Roles of Apoptosis, Inflammation, and Fibrosis. Hypertension 38, 581-587 (2001).
10. Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J. & Touyz, R. M. Angiotensin II and vascular injury. Curr Hypertens Rep 16, 431 (2014).
11. Boegehold, M. A., Drenjancevic, I. & Lombard, J. H. Salt, Angiotensin II, Superoxide, and Endothelial Function. Compr Physiol 6, 215-254 (2015).
12. Higuchi, S. et al. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112, 417-428 (2007).
13. Lacolley, P., Regnault, V., Nicoletti, A., Li, Z. & Michel, J. B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95, 194-204 (2012).
14. Sahara, M. et al. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Cardiovasc Res 101, 236-246 (2014).
15. Dugourd, C., Gervais, M., Corvol, P. & Monnot, C. Akt is a major downstream target of PI3-kinase involved in angiotensin IIinduced proliferation. Hypertension 41, 882-890 (2003).
16. Xi, X. P. et al. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19, 73-82 (1999).
17. Shen, Y. J. et al. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation. J Nat Med 68, 623-629 (2014).
18. Garrido, A. M. & Griendling, K. K. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302, 148-158 (2009).
19. Martine Torres, H. J. F. Redox signaling and the MAP kinase pathways. BioFactors 17, 287-296 (2003).
20. Lee, H. et al. Activation of PPARdelta counteracts angiotensin II-induced ROS generation by inhibiting rac1 translocation in vascular smooth muscle cells. Free Radic Res 46, 912-919 (2012).
21. Ferrario, C. M. & Iyer, S. N. Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul Pept 78, 13-18 (1998).
22. Silva, D. M. et al. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28, 702-707 (2007).
23. Jiang, F. et al. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol 11, 413-426 (2014).
24. Shi, Y. et al. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci (Lond) 128, 649-663 (2015).
25. Li, Y. H. et al. Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats. J Geriatr Cardiol 10, 151-158 (2013).
26. Alzayadneh, E. M. & Chappell, M. C. Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2. Cell Signal 26, 3027-3035 (2014).
27. Feltenberger, J. D. et al. Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice. Hypertension 62, 324-330 (2013).
28. Carver, K. A., Smith, T. L., Gallagher, P. E. & Tallant, E. A. Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation 22, 19-27 (2015).
29. Van Thiel, B. S., van der Pluijm, I., te Riet, L., Essers, J. & Danser, A. H. The renin-angiotensin system and its involvement in vascular disease. Eur J Pharmacol 763, 3-14 (2015).
30. Panchatcharam, M. et al. Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling. Int J Biochem Cell Biol 42, 965-974 (2010).
31. Karki, R., Ho, O. M. & Kim, D. W. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells. Biochim Biophys Acta 1830, 2619-2628 (2013).
32. Nagayama, K. et al. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways. Plos One 10, e0137960 (2015).
33. Alvarez, E., Rodino-Janeiro, B. K., Ucieda-Somoza, R. & Gonzalez-Juanatey, J. R. Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells. J Cardiovasc Pharmacol 55, 203-212 (2010).
34. Nair, A. R., Ebenezer, P. J., Saini, Y. & Francis, J. Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells. Exp Cell Res 335, 238-247 (2015).
35. Husain, K., Hernandez, W., Ansari, R. A. & Ferder, L. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem 6, 209-217 (2015).
36. Colie, S., Pecher, C., Girolami, J. P. & Blaes, N. Modulation by bradykinin and nitric oxide of angiotensin II-induced apoptosis in a vascular smooth muscle cell phenotype. Int Immunopharmacol 8, 231-236 (2008).
37. Ruiz, E. et al. Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan. Eur J Pharmacol 567, 231-239 (2007).
38. Ehlers, P. I., Nurmi, L., Turpeinen, A. M., Korpela, R. & Vapaatalo, H. Casein-derived tripeptide Ile-Pro-Pro improves angiotensin-(1-7)- and bradykinin-induced rat mesenteric artery relaxation. Life Sci 88, 206-211 (2011).
39. Qi, Y. et al. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol 96, 863-874 (2011).
40. Bihl, J. C. et al. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFsmall ka, CyrillicB inflammatory pathway. Vascul Pharmacol 73, 115-123 (2015).
41. Zhang, F., Hu, Y., Xu, Q. & Ye, S. Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. Plos One 5, e12323 (2010).
42. Jin, H. Y. et al. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production. Plos One 7, e38502 (2012).
43. Cai, H., Griendling, K. K. & Harrison, D. G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends in Pharmacological Sciences 24, 471-478 (2003).
44. Zhao, Q., Zhang, J. & Wang, H. PGC-1a limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen species. Biosci Rep 35, e00252 (2015).
45. Bruder-Nascimento, T. et al. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1- dependent reactive oxygen species generation. J Mol Cell Cardiol 66, 18-26 (2014).
46. Kirabo, A. et al. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res 91, 171-179 (2011).
47. Ding, K. et al. Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production, and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med 15, 81 (2015).
48. Han, Y. et al. Superoxide anions in the paraventricular nucleus mediate the enhanced cardiac sympathetic afferent reflex and sympathetic activity in renovascular hypertensive rats. J Appl Physiol (1985) 110, 646-652 (2011).
49. Sheng-Long, C. et al. AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation. Int J Hypertens 2012, 958298 (2012).
50. Trovati, M. et al. Leptin and vascular smooth muscle cells. Curr Pharm Des 20, 625-634 (2014).
51. Hao, W. et al. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci Rep 5, 10336 (2015).
52. Kwon, S. H., Ma, S. X., Lee, S. Y. & Jang, C. G. Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells. Neurochem Int 74, 53-64 (2014).
53. Ji, L. et al. Modulation of CaV1.2 calcium channel by neuropeptide W regulates vascular myogenic tone via G protein-coupled receptor 7. J Hypertens 33, 2431-2442 (2015).
54. Sun, H. J. et al. Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta 1852, 1709-1718 (2015).
55. Zhang, M. et al. BMP-2 overexpression augments vascular smooth muscle cell motility by upregulating myosin Va via Erk signaling. Oxid Med Cell Longev 2014, 294150 (2014).
56. Han, Y. et al. c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats. Pflugers Arch 461, 437-446 (2011).